Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL30378 | 0.89 | — | — | |
| Pyridine SCHEMBL6160661 | 0.86 | TSHR (0.64) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL28322715 | 0.86 | TSHR (0.64) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL31396433 | 0.84 | — | — | |
| Pyridine SCHEMBL28109394 | 0.84 | TSHR (0.53) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL29013612 | 0.84 | TSHR (0.53) | TSHRNAPRTTDP1ALDH1A1 | |
| Pyridine SCHEMBL9011063 | 0.84 | TSHR (0.53) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL1389381 | 0.84 | TDP1 (0.53) | TSHRNAPRTTDP1ALDH1A1 | |
| Pyridine SCHEMBL11485834 | 0.83 | TSHR (0.60) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL1095589 | 0.83 | NAPRT (0.60) | TSHRNAPRTTDP1ALDH1A1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY - IP SERVICES GROUP (US) | 2012-05-31 | — | — | US | claimed |
| US-20110185788-A1 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | KOCH PETER | 2011-08-04 | — | — | US | claimed |
| EP-2275090-A2 | Microparticles prepared using an ionic liquid | Novartis AG (CH) | 2011-01-19 | — | — | EP | claimed |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | claimed |
| US-7569149-B2 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2009-08-04 | — | — | US | claimed |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | AUSBORN MICHAEL | 2006-07-06 | — | — | US | claimed |
| US-20050205493-A1 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2005-09-22 | — | — | US | claimed |
| EP-1569621-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | Novartis AG (CH) | 2005-09-07 | — | — | EP | claimed |
| EP-1529205-A2 | ANALYTICAL PROCESS | Novartis AG (CH) | 2005-05-11 | — | — | EP | claimed |
| WO-2004052340-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2004-06-24 | — | — | WO | claimed |
| WO-2004013612-A2 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | NOVARTIS AG (CH) | 2004-02-12 | — | — | WO | claimed |
| WO-2000040673-A1 | INDUSTRIAL PROCESS AND CATALYSTS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2000-07-13 | — | — | WO | claimed |
| US-5994602-A | IN THE PRESENCE OF A HYDROCARBYL ALUMINUM OR GALLIUM HALIDE AND A HYDROCARBYL-SUBSTITUTED IMIDAZOLIUM OR PYRIDINIUM HALIDE | BP CHEMICALS LIMITED (GB) | 1999-11-30 | — | — | US | claimed |
| WO-1998047616-A1 | CATALYST COMPRISING A BUFFERED IONIC LIQUID AND HYDROCARBON CONVERSION PROCESS, E.G. OLIGOMERISATION | BP CHEMICALS LIMITED (GB) | 1998-10-29 | — | — | WO | claimed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | claimed |
| EP-0791643-A1 | Lubricating oils | BP Chemicals Limited (GB) | 1997-08-27 | — | — | EP | claimed |
| EP-0693045-A1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | claimed |
| WO-1995021806-A1 | ALKYLATION PROCESS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| WO-1995021872-A1 | IONIC LIQUIDS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| US-20230372496-A1 | TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS | C4 THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| EP-2593403-B1 | METHOD FOR PRODUCING A GEL FILM AND FILTRATION MEMBRANE PREPARED WITH THIS METHOD | UNIV MONASH (AU) | 2020-03-04 | — | — | EP | disclosed |
| CN-110234627-A | Pyridinone compounds and agricultural or horticultural use fungicide using pyridinone compounds as effective component | 三井化学AGRO株式会社 | 2019-09-13 | — | — | CN | disclosed |
| US-10297396-B2 | Graphene-based films | MONASH UNIVERSITY (AU) | 2019-05-21 | — | — | US | disclosed |
| US-9751763-B2 | Material and applications therefor | MONASH UNIVERSITY (AU) | 2017-09-05 | — | — | US | disclosed |
| CN-106363170-A | Three-dimensionally shaped article and three-dimensionally shaping method | 精工爱普生株式会社 | 2017-02-01 | — | — | CN | disclosed |
| US-20160016804-A1 | GRAPHENE-BASED FILMS | MONASH UNIVERSITY (AU) | 2016-01-21 | — | — | US | disclosed |
| EP-2964572-A1 | GRAPHENE-BASED FILMS | Monash University (AU) | 2016-01-13 | — | — | EP | disclosed |
| CN-103880727-B | A kind of halo sulphur compound and its preparation method and application | LUZHOU DONGFANG AGROCHEMICAL CO., LTD. (CN) | 2016-01-13 | — | — | CN | disclosed |
| WO-2014134663-A1 | GRAPHENE-BASED FILMS | MONASH UNIVERSITY (AU) | 2014-09-12 | — | — | WO | disclosed |
| CN-103694122-A | 2,2',4,4',6,6'-hexanitro diphenylethylene preparation method | XIAN MODERN CHEMISTRY RES INST | 2014-04-02 | — | — | CN | disclosed |
| US-20130180912-A1 | MATERIAL AND APPLICATIONS THEREFOR | MONASH UNIVERSITY (AU) | 2013-07-18 | — | — | US | disclosed |
| EP-2593403-A1 | MATERIAL AND APPLICATIONS THEREFOR | Monash University (AU) | 2013-05-22 | — | — | EP | disclosed |
| CN-103102349-A | Protein kinase inhibitor and composition and application thereof | BEIJING CENTAURUS BIOPHARMA TECHNOLOGY CO LTD | 2013-05-15 | — | — | CN | disclosed |
| US-8276664-B2 | Well treatment operations using spherical cellulosic particulates | BAKER HUGHES INCORPORATED (US) | 2012-10-02 | — | — | US | disclosed |
| US-20120220775-A1 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | LOHSE OLIVIER (FR) | 2012-08-30 | — | — | US | disclosed |
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY - IP SERVICES GROUP (US) | 2012-05-31 | — | — | US | disclosed |
| EP-2414335-A2 | A PROCESS FOR THE PURIFICATION OF ESLICARBAZEPINE ACETATE | Glenmark Generics Limited (IN) | 2012-02-08 | — | — | EP | disclosed |
| US-20120022047-A1 | PROCESS FOR THE PURIFICATION OF ESLICARBAZEPINE ACETATE | GLENMARK GENERICS LTD (IN) | 2012-01-26 | — | — | US | disclosed |
| WO-2012006657-A1 | MATERIAL AND APPLICATIONS THEREFOR | MONASH UNIVERSITY (AU) | 2012-01-19 | — | — | WO | disclosed |
| WO-2011112514-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY (US) | 2011-09-15 | — | — | WO | disclosed |
| US-20110185788-A1 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | KOCH PETER | 2011-08-04 | — | — | US | disclosed |
| EP-1613599-B8 | A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES | NOVARTIS AG (CH) | 2011-06-22 | — | — | EP | disclosed |
| US-20110140885-A1 | SENSOR FOR CONTAINER MONITORING SYSTEM | HUMMER GREGORY J | 2011-06-16 | — | — | US | disclosed |
| CN-102089311-A | Morphinan synthesis process | PHOENIX PHARMALABS INC | 2011-06-08 | — | — | CN | disclosed |
| EP-2275090-A2 | Microparticles prepared using an ionic liquid | Novartis AG (CH) | 2011-01-19 | — | — | EP | disclosed |
| EP-1613599-B1 | A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES | NOVARTIS AG (CH) | 2010-12-15 | — | — | EP | disclosed |
| WO-2010113179-A2 | A PROCESS FOR THE PURIFICATION OF ESLICARBAZEPINE ACETATE | GLENMARK GENERICS LIMITED (IN) | 2010-10-07 | — | — | WO | disclosed |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | disclosed |
| EP-1791820-B1 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | NOVARTIS AG (CH) | 2009-12-02 | — | — | EP | disclosed |
| US-7605267-B2 | Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | NOVARTIS AG (CH) | 2009-10-20 | — | — | US | disclosed |
| US-20090199622-A1 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | KOCH PETER | 2009-08-13 | — | — | US | disclosed |
| US-7569149-B2 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2009-08-04 | — | — | US | disclosed |
| US-20090054653-A1 | ENANTIOSELEKTIVE PREPARATION OF QUINOLINE DERIVATIVE | LOHSE OLIVIER | 2009-02-26 | — | — | US | disclosed |
| US-20090044942-A1 | Cellulosic Particulates and Method of Manufacture and Use Thereof | BJ SERVICES COMPANY | 2009-02-19 | — | — | US | disclosed |
| EP-1791820-A2 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | Novartis AG (CH) | 2007-06-06 | — | — | EP | disclosed |
| US-20060189653-A1 | Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | NOVARTIS AG (CH) | 2006-08-24 | — | — | US | disclosed |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | AUSBORN MICHAEL | 2006-07-06 | — | — | US | disclosed |
| CN-1774423-A | Process for the preparation of 5- (haloacetyl) -8- (substituted oxy) - (1H) -quinolin-2-ones | NOVARTIS AG (CH) | 2006-05-17 | — | — | CN | disclosed |
| EP-1613599-A1 | A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES | Novartis AG (CH) | 2006-01-11 | — | — | EP | disclosed |
| WO-2005123684-A2 | ENANTIOSELEKTIVE PREPARATION OF QUINOLINE DERIVATIVE | NOVARTIS AG (CH) | 2005-12-29 | — | — | WO | disclosed |
| US-20050205493-A1 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2005-09-22 | — | — | US | disclosed |
| EP-1569621-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | Novartis AG (CH) | 2005-09-07 | — | — | EP | disclosed |
| EP-1529205-A2 | ANALYTICAL PROCESS | Novartis AG (CH) | 2005-05-11 | — | — | EP | disclosed |
| WO-2004087668-A1 | A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES | NOVARTIS AG (CH) | 2004-10-14 | — | — | WO | disclosed |
| WO-2004052340-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004013612-A2 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | NOVARTIS AG (CH) | 2004-02-12 | — | — | WO | disclosed |
| CN-1058694-C | Alkylation process | BP CHEM INT LTD (GB) | 2000-11-22 | — | — | CN | disclosed |
| WO-2000041809-A1 | IONIC LIQUID CATALYST FOR ALKYLATION | BP CHEMICALS LIMITED (GB) | 2000-07-20 | — | — | WO | disclosed |
| US-5994602-A | IN THE PRESENCE OF A HYDROCARBYL ALUMINUM OR GALLIUM HALIDE AND A HYDROCARBYL-SUBSTITUTED IMIDAZOLIUM OR PYRIDINIUM HALIDE | BP CHEMICALS LIMITED (GB) | 1999-11-30 | — | — | US | disclosed |
| WO-1998047616-A1 | CATALYST COMPRISING A BUFFERED IONIC LIQUID AND HYDROCARBON CONVERSION PROCESS, E.G. OLIGOMERISATION | BP CHEMICALS LIMITED (GB) | 1998-10-29 | — | — | WO | disclosed |
| US-5691053-A | Coating composition with thermally-influenced color | DAIMLER-BENZ AG (DE) | 1997-11-25 | — | — | US | disclosed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | disclosed |
| EP-0791643-A1 | Lubricating oils | BP Chemicals Limited (GB) | 1997-08-27 | — | — | EP | disclosed |
| CN-1123023-A | Alkylation process | BP CHEM INT LTD (GB) | 1996-05-22 | — | — | CN | disclosed |
| EP-0558187-B1 | Butene polymers | BP CHEM INT LTD (GB) | 1996-04-10 | — | — | EP | disclosed |
| EP-0693045-A1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | disclosed |
| WO-1995021872-A1 | IONIC LIQUIDS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | disclosed |
| WO-1995021806-A1 | ALKYLATION PROCESS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | disclosed |
| US-5304615-A | Aluminium compounds with imidazolium and pyridinium halides | BP CHEMICALS LIMITED (GB) | 1994-04-19 | — | — | US | disclosed |
| EP-0558187-A1 | Butene polymers | BP Chemicals Limited (GB) | 1993-09-01 | — | — | EP | disclosed |
| EP-0558187-A1 | Butene polymers | BP Chemicals Limited (GB) | 1993-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372496-A1 | TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS | CRBN, CDR2, MDM2 | TSHR 3035/4885NAPRT 2808/4885TDP1 1939/4885 |
| US-20120022047-A1 | PROCESS FOR THE PURIFICATION OF ESLICARBAZEPINE ACETATE | CACNA1A, GABRE, CACNA1D | TSHR 3720/4885NAPRT 3405/4885TDP1 4490/4885 |
| US-20090054653-A1 | ENANTIOSELEKTIVE PREPARATION OF QUINOLINE DERIVATIVE | HAX1, OPRK1, OPRD1 | TSHR 2165/4885NAPRT 2501/4885TDP1 1997/4885 |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | FIBP, MIF, CHMP4B | TSHR 3760/4885NAPRT 4128/4885TDP1 1587/4885 |
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | OSBPL8, OSBP, OSBP2 | TSHR 2589/4885NAPRT 2710/4885TDP1 2022/4885 |
| US-20120220775-A1 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | OPRM1, OPRD1, HAX1 | TSHR 2128/4885NAPRT 2561/4885TDP1 2185/4885 |
| US-20060189653-A1 | Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | UGT8, KAT8, UGT1A8 | TSHR 1260/4885NAPRT 1072/4885TDP1 3103/4885 |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | FIBP, MIF, CHMP4B | TSHR 3760/4885NAPRT 4128/4885TDP1 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.